implication
presence
epidemiol
identifying
ibnu
hormone
mostly
washington
found
gene
recognizing
LCIS
hypoechoic
multifocal
restrict
microscopic
solid
beyond
AA
coronary
margin
localisation
lymphatic
change
DJ
count
highest
used
according
table
volume
divided
familie
strategie
greater
profile
echogenicity
invasion
identification
pattern
radiological
reaching
emphasizing
2226
applicability
CT
2199
imaging
impact
assessment
830
absolute
area
referral
percutaneou
carried
2014
longitudinal
positive
lembo
precision
level
activity
genetic
pathological
wherea
gelmon
coate
sedentary
via
global
treated
interest
lymphocyte
mikhail
face
goldhirsch
evaluation
umi
multifocality
undergoing
heal
clinico
degree
minimal
2022
measured
gro
HOSPITAL
little
centimeter
methylator
out
publication
JE
altered
100565
further
paper
observed
random
making
HER2
AJCC
nor
pathologic
research
exhibiting
round
case
neoadjuvant
amin
grade
tumor
baghdad
show
turner
using
seen
specific
therapy
mas
localization
region
clinically
vital
low
remain
annual
poorly
usually
contrast
pre
carcinoma
associated
group
contraceptive
makassar
eribulin
cardiol
importance
invasivenes
approache
epigenetic
absent
through
differentiated
kesehatan
predominantly
549
inference
indek
other
hormonal
women
several
histopathological
syndrome
testing
MG
small
les
548
HM
spread
participant
com
enhance
agency
infiltration
430
consisted
latief1
relationship
cappelletti
present
late
gap
disparitie
ductal
free
studie
worldwide
index
tracking
reviewing
detectable
marked
our
natural
cancer
different
expression
island
attenuated
clearly
socioeconomic
generalizability
comparing
aiuto
strongly
within
cohort
springer
journal
study
ravdin
human
included
protocol
identify
sulawesi
national
commonly
limitation
uneven
demonstrated
typically
2025
biological
may
muslim
visi
collected
martelli
mortality
subtype
echo
data
infiltrative
causal
notable
slamon
department
program
approval
understanding
ultrasound
ethic
intervention
diameter
ha
estrogen
boundarie
jneonatalsurg
value
develop
compton
platelet
latief
FL
limit
exposure
evaluate
term
2017
morphology
organ
around
APJCP
lymph
also
overexpression
easier
average
blurred
zhu
vol
oestrogen
majority
death
planning
despite
poorer
overall
examination
comorbiditie
related
000
necrosi
early
about
comparative
yerushalmi
definition
andy
jia
brenner
liver
MM
assessed
kartika
zhang
affect
exam
toll
expert
ABSTRACT
widely
guide
parameter
align
eur
record
future
rise
easily
account
reviewed
not
visible
identified
providing
US
neovascularization
conspicuou
enriched
decrease
receptor
risk
large
evaluated
SINA
independent
cell
increased
universita
progression
RK
greene
variable
exhibited
tended
radiology
separate
tend
observation
1024
population
elderly
key
patche
fatal
rarely
affected
ultrasonographic
apr
improving
unlike
winer
good
obesity
re
who
prognosi
due
leading
masse
microcirc
approved
care
diversity
offer
BMC
trastuzumab
hospital
statement
either
developing
851
each
CA
wahidin
simple
337
ki67
precise
shown
fulvestrant
very
NNH
KF
550
reported
final
2021
among
exist
fact
overexpres
genomic
proteomic
551
deeper
new
correlational
surgery
basic
paclitaxel
therapeutic
aberrant
WA
approximately
molecular
lung
combination
symptom
contribute
example
relevant
issue
shofiyah
shift
radiologically
VI
prolonged
advanced
represent
thuerlimann
http
AM
tendency
including
kartika2
particularly
189
RD
six
eighth
contrary
MK
criteria
alqahtani
kementerian
haye
initial
858
internet
surrounding
room
well
diagnosi
physical
personalized
recognized
based
djuwita
UMI
incidence
medical
center
local
versu
radiol
lump
egypt
histological
lodi
smaller
novel
oval
causing
INTRODUCTION
play
mol
edge
there
discussion
entirely
metastasi
angiogenesi
content
NA
retrospective
noticeable
epidermal
CONCLUSION
displayed
detection
333
university
byrd
DCIS
qualitie
high
course
mechanobiology
crucial
furthermore
few
into
lancet
sign
thorough
showed
cros
reflect
recurrence
type
gathered
underscore
proliferation
clear
characteristic
indonesia
information
republik
115
ann
disclosure
microcalcification
scan
them
delayed
RI
NC
analysi
wall
indicating
registry
screening
period
after
payudara
multicenter
instance
detected
wang
lifestyle
unclear
critical
likelihood
decision
histopathology
aggressive
demonstrate
brookland
gebhart
distinction
size
considerable
keyword
asian
statistical
treat
morphological
showing
their
correlation
174
metabolic
history
2004
ibrahim
faculty
acros
health
none
control
situ
recommended
USG
consistent
individual
postmenopausal
solitary
often
frequently
development
declare
lower
optimizing
diferensiation
statu
predictive
predominating
musella
imaginng
submission
two
latency
KEP
disease
379
obviou
lymphovascular
notably
although
such
kamel
clarify
association
PM
full
variation
caregiver
lympho
MB
mutation
apparent
while
include
2020
essential
routine
macrocalcification
tailoring
node
highlight
enhanced
both
grading
guiding
feature
MA
growth
painles
homogen
sectional
internal
clinicopathological
oral
accompanied
vascularization
masuda
conclusion
response
vascular
time
heitz
frequent
dramatically
acknowledgement
REFERENCES
depending
ultrasonography
2024
healthcare
METHOD
firm
hand
edition
kanker
especially
significant
review
mechanism
likely
regular
organization
2016
hoffmeister
protein
scheer
neither
influencing
setting
KA
657
big
wa
power
2018
similarly
detail
confined
involve
clinical
however
stage
552
single
bondarenko
instability
available
derived
revealed
common
EP
factor
challenge
respectively
saudi
gallen
appeared
resistin
patient
biomarker
neovascularisation
pertuzumab
petel
source
diagnose
bigger
major
inhibition
www
role
conflict
propertie
preoperative
distinct
differ
surg
TM
gao
proliferative
averaging
variou
ID
clopidogrel
online
AS
bioeng
consisting
seem
intermediate
prediction
choice
calcification
plu
cpg
introduction
685
prevent
baraka
presentation
bridge
colorectal
presented
sheet
contributed
gershenwald
markedly
233
observatory
defined
breast
indistinct
indicate
conversely
imamura
old
year
tissue
multicentric
predominate
lesion
manual
just
more
carin
neonatal
determined
enlarged
worse
resistance
piccart
long
rate
poor
limiting
engl
ranging
DR
outcome
locally
kobayashi
improve
CC
consistency
could
assessing
IBNU
metastatic
personalizing
ito
like
comprehensive
method
228
than
prev
RESULTS
increase
enlargement
1380
MR
diagnostic
most
BRCA1
aggressivenes
wood
fukada
but
build
it
non
166
sina
involvement
reix
micro
consensu
reveal
plainly
nab
moderate
med
they
potential
possibly
invading
thiebaut
age
compared
547
additionally
prominent
homogeneou
discussed
pathophysiology
reducing
213
abnormal
arabia
localised
strong
confirmed
MS
between
ethical
hazy
support
centre
SB
marker
funding
target
lack
profiling
linked
email
finding
limfovaskular
0439
board
progesterone
palbociclib
metagene
negative
irregular
lumpectomy
sample
cause
primary
ISSN
IA
structure
BRCA2
concern
selection
having
varie
jakarta
management
oncol
prevalent
IV
important
adjuvant
dose
uniform
pacific
system
advance
adisasmita
callari
international
treatment
hemorheol
larger
will
additional
distant
systematic
all
morbidity
1926
province
metastase
characterized
number
546
luminal
significantly
regional
ranking
higher
sampling
asses
committee
previou
119
positivity
nakano
morphologically
drop
437971
staging
world
contribution
detailed
2010
appearance
current
mammography
cite
khaled
hypervascular
biology
642
design
cited
MH
2023
follow
quantitative
DISCUSSION
rahman
araki
estimated
approach
survival
clin
2206
miyagawa
female
biol
resolution
shape
fulfilled
measure
III
lobular
look
prognostic
GCO
appl
anatomic
being
immunohistochemistry
difference
MAKASSAR
tumour
extremely
2013
int
technique
surgical
23
jakubowski
phenotype
PET
severe
reflecting
appear
differentiation
accuracy
significance
conducted
result
invasive
necrotic
descriptive
continuing
gelber
older
tailored
doppler
insight
tool
author
had
exhibit
south
BRG